Study on the application of B-natriuretic peptide and cytokines in congestive heart failure

›› 2004, Vol. 19 ›› Issue (05): 438-440.

• 免疫学检验论著 • Previous Articles Next Articles

CLC Number:

[1]	JIN Hongwei;YANG Guang;HUANG Heqin. Screening and analysis of biomarkers of esophageal cancer by combined technology of size exclusion chromatography and matrix assisted laser desorption ionization-time of flight-mass spectrometry [J]. , 2009, 24(11): 792-795.
[2]	TANG Jibin;CHEN Jizhong;L(U) Ming;JIANG Kaiming;WANG Yaqin. The interferential effect of reduced glutathione hormone on biochemical test items relating oxydase reaction [J]. , 2007, 22(01): 25-27.
[3]	. Changes of plasma C-type-natriuretic peptide and adrenomedullin in patient with chronic obstructive pulmonary disease [J]. , 2004, 19(05): 419-420.
[4]	. Changes and analysis of the plasma levels of B-type natriuretic peptide, endothelins, C-reactive protein and A-type natriuretic peptide in the patients with acute myocardial infarction [J]. , 2004, 19(03): 242-244.
[5]	. Measurment of B-type natriuretic peptide with a rapid quantitative fluorescence immunoassay (Triage(R)) for the diagnosis of congestive heart failure [J]. , 2004, 19(03): 239-241.
[6]	. Detection of endothelin level in patients with cerebral thrombus within 24 hours [J]. , 2004, 19(02): 98-100.
[7]	. [J]. , 2002, 17(06): 367-368.
[8]	. A study of relationship between conter of gastrin releasing 　peptide and small cell lung carcinoma [J]. , 2001, 16(05): 281-282.

PDF (PC)